Evidence map›Paper›PMID 40442302›Full record

ArticleScientific reports2025

Harnessing AI to revolutionize photocatalytic degradation of Tetracycline via optimized UV/ZrO

Amir Sheikhmohammadi, Saeed Hosseinpour, Zahra Jalilzadeh, Hossein Azarpira, Mahmood Yousefi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. ZrORSC advances · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amir SheikhmohammadiDepartment of Environmental Health Engineering, School of Health, Khoy University of Medical Sciences, Khoy, Iran.
Saeed HosseinpourDepartment of Environmental Health Engineering, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
Zahra JalilzadehStudent Research Committee, Khoy University of Medical Sciences, Khoy, Iran.
Hossein AzarpiraDepartment of Environmental Health Engineering, Social Determinants of Health Research Center, Saveh University of Medical Sciences, Saveh, Iran. hazarpira912@gmail.com.
Mahmood YousefiDepartment of Environmental Health Engineering, School of Health, Khoy University of Medical Sciences, Khoy, Iran. Mahmood_yousefi70@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper assesses the presentation of Gradient Boosting Regression (GBR), Ridge Regression (RR), and Particle Swarm Optimization (PSO) models in improving the photocatalytic destruction of antibiotic utilizing a UV/ZrO₂/NaOCl system. The GBR model indicated the strength of exhibited precision, with high R² and Explained Variance Score (EVS) esteems, however gave indications of overfitting. Remarkably, the RR model obtained had many significant values and the model had a high data fitness with an R² of 0.81; however, error bars were observed in some areas that could be optimized by fine-tuning. Feature significance examination indicated that X2, X1, and X5 fundamentally affected the model's performance. At last, PSO was instrumental in finding the ideal limit mix to support removal performance. Altogether the presented models help to improve the photocatalytic degradation process and provide useful tools for further investigation in this field.

Indexed as

Anti-Bacterial AgentsArtificial IntelligenceTetracyclineUltraviolet RaysCatalysisPhotolysisAnti-Bacterial AgentsTetracyclineArtificial intelligence modelsPhotocatalytic degradationReaction pathway enhancementTetracycline removalUV/ZrO₂/NaOCl optimization

Identifiers

PMID40442302
PMCPMC12122820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.